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ABSTRACT 
A Study on the Applications and Toxicity Assessments of Carbon Nanotubes 
 in Tissue Engineering 
by 
Rena Baktur, Master of Science  
Utah State University, 2011 
Major Professor: Dr. Soonjo Kwon 
Department: Biological Engineering 
 
Carbon nanotubes (CNTs) are one of the most popular nanomaterials. There has 
been increasing interest in the development and applications of carbon nanotubes due to 
their huge potential in industrial and medical applications. Recent applications of carbon 
nanotubes include development of scaffolds and drug delivery systems. Despite rapidly 
emerging applications of CNTs, little is known about the impact of CNTs on cellular 
processes, especially mesenchymal stem cell (MSC)’s differentiation. Also, the effects of 
nanoparticle exposure under different conditions on cellular responses have not been well 
characterized yet. 
 To characterize the effects of CNTs on creating nanoscale scaffolds for tissue 
engineering, we incorporated multi-walled CNTs (MWCNTs) into reconstituted type I 
collagen, and evaluated proliferation, differentiation, mineralization and inflammatory 
response of MSC on those scaffolds. MWCNTs were homogeneously distributed in 
collagen matrix, and strongly entrapped in collagen at the concentrations below 100 ppm. 
Alkaline phosphatase (AP) activity and mineralized nodules of extracellular matrix (ECM) 
iv 
 
 
 
were monitored as osteogenic differentiation markers. AP activity was significantly 
increased in 12 days after being replaced by differentiating media.  Collagen enhanced 
AP activity, and MWCNT-collagen scaffolds induced additional increase in AP activity. 
The MSC released a significantly higher level of AP on MWCNT-collagen scaffolds than 
the plastic surface did at day 16. An increasing percentage of ECM mineralization was 
seen at day 16 after being replaced by differentiating media in the presence of MWCNT-
collagen scaffolds. This study indicated the possibility of enhancement in MSC 
differentiation in the MWCNT-collagen scaffolds. The increased level of differentiation 
markers was due to the increased stiffness of the scaffolds for MSC. Our data indicated 
that the collagen-MWCNT scaffolds might have the potential application to create 
nanoscale scaffold materials for tissue engineering. 
To illustrate the effects of interleukin-8 (IL-8) expression in human alveolar 
epithelial cells (A549) under various exposure conditions of CNT, we measured the level 
of IL-8 expression in the presence and absence of serum following exposure of SWCNTs. 
The results demonstrated that the IL-8 expression was enhanced in the presence of serum.  
The IL-8 expression kept increasing at low concentration even after removing SWCNTs 
from the media. Further studies are required to characterize biological functions and 
toxicological potentials of nanomaterials.  
 
 
                                                                                                                   (99 pages)
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CHAPTER 1 
INTRODUCTION 
1.1 Background 
Over the past decade, rapid development in nanoscience and nanotechnology has 
resulted in the successful synthesis and characterization of various inorganic 
nanomaterials.
1-3
  The unique physical properties of the nanopaticles, such as their 
extremely small size, make them highly suitable for a wide range of biological and 
medical applications.  In all those nanoparticles, carbon nanotubes (CNTs) have been the 
focus of intense research that was motivated by their unique physical, chemical and 
mechanical properties, since they were discovered by Iijima in 1991.
4
 
Carbon nanotubes (CNTs) are a new generation of materials possessing superior 
mechanical, thermal, and electrical properties.
5,6
 They are mosaics of carbon atoms that 
form graphene sheets and curl into seamless tubules. CNTs are classified as single-walled 
CNTs (SWCNTs) and multi-walled CNTs (MWCNTs) based on the number of graphene 
layers. CNTs exhibit unique properties that have made them an attractive material for the 
application in molecular electronics,
7
  medical diagnostics, biosensors,
8
 and drug delivery 
carriers.
9
 
The CNTs have been proposed for biomedical applications, such as cell tracking 
and labeling, nano-sensors, and vehicling for controlled release of drugs, and vehicling 
for delivery of bioactive agents. Synthetic polymers and CNTs have demonstrated 
promise for these materials in neural and orthopedic tissue engineering applications. 
When CNTs are used as scaffold materials in regenerative medicine, especially in bone 
tissue engineering, they are in direct contact with the bone. These included implants for 
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arthroplasty, bone fracture, dental treatment and scaffolds for bone tissue regeneration. 
The reaction of the bone cells to CNTs is critical for functional maintenance of the 
biomaterials for a long time in the tissues. Recently, there have been several reports on 
the application of CNTs for scaffolds. For example, CNTs coated with bioactive 
molecules were used as substrates for nerve cell growth.
10
 Also in Webster’s study they 
reported that carbon nanofibers increased osteoblast functions. MacDonald reported a 
collagen-SWCNT composite for cell culture substrate.
11
 However, there is a limit amount 
of information about the CNT and collagen mixture scaffold for stem cell growth.  This 
give researchers a new idea to use collagen-CNT composite to check stem cell 
biocompatibility. 
On the other hand, enthusiasm for CNTs use has been tempered by relevant 
concerns regarding their toxicity. The high aspect ratio of CNTs made them easily 
become airborne and inhaled.  The  evaluation of their pulmonary effects has received a 
considerable amount of interest and emerge studies investigate the toxicity of CNTs in 
vivo and in vitro. Most of the emerging literatures on the toxicity of CNTs on the lung 
tissue of various animal models have been reported and appared to be inconsistent amony 
the research findings. Some of the researches confirmed that CNTs can have toxic effects, 
and some of the toxic effects in mammals have been attributed to high concentration of 
CNTs. There also have been a range of in vitro studies using human or mammalian cell 
lines to investigate the toxicity mechanisms, which suggest that oxidative stress, 
inflammation reactions, and immune toxicity may be key features of CNT toxicity. Most 
of the studies that suggest CNT toxicity used a high concentration of CNT to expose the 
cell line or to inject the animal. However, there was no specific number about how much 
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CNT will get inhaled in to human body and in the environment. Small amount of CNTs 
inhaled effect is still unknown and the machines of CNTs to airway inflammation 
reactions need to be indicated. 
1.2 Motivation and Objectives of Research 
Carbon nanotubes (CNTs) and other carbon nanomaterials are of interest for 
biological and medical applications because of their high chemical durability, mechanical 
strength and electrical properties. Studies on the applications of carbon nanomaterials 
have been carried for the substrate of cell culture,
12-14
 drug delivery systems
15,16
 and 
medical implant materials.
17
 Several studies have shown  that cells have high affinity to 
CNTs.
18-20
 Other studies that showed the bone cell affinity to CNTs and bone formations 
on sintered MWCNTs
21
. During those studies, MacDonalds provided a good idea for 
using collagen and CNTs to make a good composite material, which show high 
mechanical strength and good cell viability.  However, until now there are no studies that 
use collagens - CNTs composite materials to make a scaffold to culture mesenchymal 
stem cells (MSC), especially a good composite material with good optically transparent. 
Thus, in our study, we  
a) Designed CNTs-collagen composite scaffolds using different types of MWCNTs  
(functionalized and non-functionalized) with good optically transparent. 
b) Estimated mesenchymal stem cell’s viability, differentiation, mineralization and 
inflammatory response on those types of CNTs-collagen scaffolds. 
c)   Measured the mechanical properties of those CNTs-collagen scaffolds. 
Carbon nanotubes have gained enormous popularity due to a variety of potential 
applications which will ultimately lead to increased human and environmental exposure 
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to these nanoparticles. The lung is regarded as one of the main portals of entry for 
nanoparticles, which emphasizes the importance of pulmonary toxicity evaluation. The 
lung epithelium plays an important role in the modulation of inflammatory processes by 
releasing inflammatory cytokines such as IL-8 and nitric oxide 
22-24
. However, the effects 
of concentration, exposure time, media component and aggregation of CNTs on cellular 
toxicity and their mechanisms have not been well defined. In the second study, we 
estimated effect of exposure conditions on SWCNT-induced inflammatory response in 
human alveolar epithelial cells. This study was spurred by the following fundamental 
questions:  
a) What other environmental factors (e.g. exposure time, media components) may affect 
the SWCNTs related inflammatory responses or cellular toxicity?  
b) Is SWCNTS induced inflammatory response alleviated by removing SWCNTS 
following exposure?  
Chapter 1 describes general introduction and motivations of studies on the 
applications and toxicity assessments of carbon nanotubes in tissue engineering. In 
chapter 2, Literature Review introduced researches about the CNTs biomedical 
applications, especially in bone tissue engineering applications. It also looked at  the 
toxicity study of CNTs, both in vivo and in vitro, especially on human alveolar epithelial 
cells. Chapter 3 exhibited the research related to effect of Carbon nanotubes –collagen 
composite scaffold on mesenchymal stem cell proliferation, differentiation, 
mineralization and inflammatory response. Chapter 4 contained the study about the effect 
of exposure conditions on SWCNT-induced inflammatory response in human alveolar 
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epithelial cells.  Based on the experimental data in chapter 3 and chapter 4, conclusions 
and recommendations were given in chapter 5. 
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CHAPTER 2 
LITERATURE REVIEW 
2.1 Carbon nanotubes  
Carbon nanotubes (CNTs) are one of the new class materials for industrial and 
biomedical applications. Sumio Iijima discovered multiwall CNT (MWCNTs) in 1991 by 
an arc-discharge method.
1,2
 After two years, he made the observation of single-walled 
nanotubes (SWCNTs).
3
 Since then, CNTs have captured the attention of researchers 
worldwide.  
CNTs are allotropes of carbon with a cylindrical nanostructure. They are a 
seamless cylindrical sheet of graphite whose diameter is nano scale and its aspect ratio 
(diameter verses length ration up to 132000000:1) is significantly larger than any other 
materials.
4
 CNTs not only exhibit extraordinary strength but also are the stiffest materials 
have been found on the earth yet. 
CNTs are categorized as SWCNTs and multi-walled nanotubes (MWCNTs). A 
SWCNT is a nano size tube formed by bonded carbon atoms arranged in a hexagonal 
pattern. An individual SWCNT is a very thin tube at least several micrometers long, the 
diameter of the SWCNTs are vary between about 0.7 and 3 nm,
5
 with an aspect ratio 
greater than 1000.
6
 Structurally, it resembles a rolled up single layer of graphite sheet. 
MWCNTs have two or more concentric layers with various diameters (generally range 
from 10 to 200 nm)
7
 and lengths. MWCNTs generally exist in single tubes and form very 
few bundles.  Both of SWCNTs and MWCNTs have van der Waals forces between the 
molecules, this causes them to aggregate into microscopic bundles or topes. However, the 
MWCNTs are less effective than the SWCNTs.
8
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On the other hand, the lack of solubility and the difficult manipulation in any 
solvents have imposed great limitations to the use of CNT. They can be dispersed in 
some solvents by sonication, but precipitation immediately occurs when this process is 
interrupted. It has been demonstrated that CNT can interact with different classes of 
compounds
9-11
. Extensive research on CNTs focuses on modifying CNTs by adding 
specific chemical groups, leading to a significant change in their properties (Like –OH, -
COOH, -NH2). 
Commercially, CNTs are produced from carbon atoms found in graphite by arc 
discharge , by pulsed laser vaporization
12
, and by a chemical-vapor deposition (CVD) 
process
13
. Nowadays, the most common synthesis method is the HiPco process which 
was developed in the Smalley’s laboratory14.  CNTs samples invariably contain some 
residual impurities. Usually they are metals, organics, and support materials. The most 
commonly used metals in CNT synthesis are Co, Fe, Ni and Mo. Post production 
processing removes the majority of metal catalyst. However, CNTs may still contain 
some residual metal by mass. In our research, we used many different types and different 
sizes of CNTs. All CNTs we bought are made by HiPco method.  The Table 2.1 showed 
the detail information about the MWCNTs we used in our research. 
2.2 Carbon Nanotubes Applications 
The nano scale of nature has logically given rise to the interest in using 
nanomaterials for tissue engineering and biomedical field. In the medical field, 
biomaterials are expected to be developed using CNTs for clinical use.  Since 2000, with 
CNT high aspect ratio, electrical and physical properties, there has been an approximate 
doubling each year of articles related to CNT for use in biomedical application. Also the 
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research have increased rapidly from 2005 and continue to increase (Figure 2.1).
15
 
However, there have been only a few cases of a truly clinical application to date, and 
therefore the use of CNTs in biomaterials must be considered to be at an early 
experimental stage. 
2.2.1 Application in biomedical: cancer, drug, and matrix 
Applications of CNTs in the field of biotechnology have recently started to 
emerge, raising great hopes. CNTs have been proposed as a component for DNA and 
protein biosensors 
16,17
, ion channel blockers 
18
 and bioseparators and biocatalysts 
19
. 
Concerning the biomedical applications of CNTs, their use is becoming relevant in 
neuroscience research and tissue engineering. Cell tracking and labeling, sensing cellular 
behavior, augmenting cellular behavior and enhancing tissue matrices are the four areas 
that CNT can be used in tissue engineering 
20
. CNTs have also been used as a new 
platform to detect antibodies associated with human autoimmune diseases with high 
specificity 
21
. In a similar context, CNT covalently have been modified at their open ends 
with DNA and RNA, and have led to innovative systems for hybridization of 
complementary DNA strands allowing for ultrasensitive DNA detection 
22
.  
Carbon nanotubes have potential novel application in nanomedicine as 
biocompatible and supportive substrates, and as pharmaceutical excipients for creating 
versatile drug delivery systems. The applications of CNTs as drug excipients are of 
interest, given their capacity to interact with macromolecules such as proteins and DNA 
23
. There are some research showed that functionalized carbon nanotubes used as vectors 
for in vitro delivery of small molecules 
24
, a potential vector for transporting proteins, 
10 
 
 
 
peptides, and genes in to the nucleus 
25-27
. Efforts are continuing to develop novel 
systems for the delivery of protective antigens.  
Table 2.1 Carbon Nanotubes (CNTs) detail information 
Types Outside 
diameter 
Inside 
diameter 
Length Components Contents (%) 
C Cl Fe Ni 
MWCNT 20-30nm 5-10nm 10-30µm 98.35    0.45     0.26    0.94 
Short MWCNT 20-30nm 5-10nm 0.5-2.0µm 98.34    0.47     0.24    0.94 
MWCNT-OH 20-30nm 5-10nm 10-30µm 98.37    0.47     0.23    0.93 
Short MWCNT-OH  20-30nm 5-10nm 0.5-2.0µm 98.32    0.48     0.25    0.94 
MWCNT-COOH 20-30nm 5-10nm 10-30µm 98.39    0.45     0.23    0.93 
Short MWCNT-COOH 20-30nm 5-10nm 0.5-2.0µm 98.34    0.46     0.25    0.94 
 
 
Figure 2.1  Number of publications on CNTs applications in biomaterials by year 
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CNTs are also potential biocompatible materials that can serve as a supportive 
matrix. The matrix plays a critical role in tissue engineering. It is responsible for defining 
the space the engineered tissue occupies and aiding the process of tissue development. 
Compared to the polymers, CNTs can easily functionalized and have good mechanical 
strength. CNTs have the potential for providing the need structural reinforcement for 
tissue scaffolds. Adding CNTs in to polymer can significantly improve the mechanical 
strength of the materials. In Wang et.al research they found MWCNT blended with 
chitosan showed significant improvement in mechanical properties compared with those 
without chitosan 
28
.  
In vitro studies have shown that CNT as a scaffold has successfully grown several 
different types of cells. For instance, smooth muscle cell have been successfully grown 
on the SWCNT with collagen scaffold 
29
. CNT scaffold support L929 mouse fibroblasts 
growth 
30
. CNT are widely used as a mimic neural fibers scaffold to guide neurite growth 
30-34
. Nowadays, researchers try to use CNT as a scaffold for bone cell growth. 
2.2.2 CNTs applications in bone tissue engineering 
A major goal in bone bioengineering is to create artificial scaffold materials that 
have the capacity to sustain bone cell growth, proliferation and increment or replace bone 
tissue. When CNTs are used in biomaterials to contact with bone, the reactions of cells 
including bone tissues to CNTs are critical. These reactions are especially important 
when CNTs are used for bone tissue engineering. These cells are mainly osteoblasts, 
osteocytes, osteoclasts, and chondrocytes. Osteoblasts, the bone forming cells, proliferate 
on the bone surface, produce and secrete bone matrix proteins. As they progress through 
stages of cell differentiation under hormonal control, they mineralize the matrix by means 
12 
 
 
 
of production of hydroxyapatite crystals. There have been several studies on the influence 
of CNTs on osteoblastic cells which are representative of these cells.  
There are some published studies on the application of CNTs to biomaterials 
associated with bone. What they did basically was expose  bone cell to different types of 
the CNTs, then checked cell proliferation and differentiation. For examples, in Zhang et 
al investigated effect of SWCNT, double walled carbon nanotubes (DWNTs) and 
MWCNT on the proliferation, differentiation, adipocytic transdifferentiation and 
mineralization of primary osteoblasts. They found the treatment of CNTs could reduce 
the viability of primary osteoblasts and inhibit the mineralization of osteoblasts in a dose-
dependent manner. Also CNT reduced the adipocytic transdifferentiations. However, the 
inhibition was not strong enough to reverse the cytotoxicity and suppression on viability 
and mineralization of primary osteoblasts 
35
. Similar results were found by Zanello group. 
They concluded that CNTs sustain osteoblast growth and bone formation. CNTs showed 
promising biocompatibility with osteoblast cells and appeared to modulate the cell 
phenotype. Thus CNTs represent a potential technological advance in the field of bone 
bioengineering
36. In Narita et al’s study they showed that MWCNTs inhibit osteoclastic 
bone resumption in vivo.MWCNTs inhibit osteoclastic differentiation and suppressed a 
transcription factor essential for osteoclastogenesis in vitro 
37
.  Recently, the main aim of 
many studies is to examine the effects of CNTs on mesenchymal stem cell viability, 
proliferation, and phenotype. Mooney et al’s study revealed that functionalized CNTs 
were easier to disperse in human mesenchymal stem cell media. Study clarified the 
COOH- functionalized SWCNT were least toxic to the cells, and the CNT had no adverse 
effects on cell biocompatibility, proliferation, or differentiation 
38
.  
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Since attention has been paid to the use of CNTs as biomaterials in contact with 
bone, it is critical to understand the reaction of bone cell to CNTs. Some of the studies 
used CNT films to test the effects of CNTs on bone cells. Kalbacova’s groupindicated 
that differently prepared SWCNT films are not toxic for human osteoblasts and could be 
used for biomedical applications 
39. In Aoki et al’s study they made CNT scaffold by 
vacuum filtration. And cell proliferation and morphology were investigated using a 
scanning electron microscopy. Osteoblast cells on CNTs showed excellent proliferation 
with extension of cell morphology in all directions 
40
. After two years, Aoki’s group 
investigated the dependence of biocompatibility of carbon materials on crystal structure 
with the aim of developing biomedical applications. They used SWCNT and MWCNT as 
scaffolds for cell culture and compared with graphite (GP). They discovered the 
osteoblast cell responses in terms of cell morphology, cell proliferation, and ALP 
activities were quite different between those carbon atom materials. With CNTs scaffolds, 
cell growth, proliferation, and functions were higher than GP. In particular, SWCNT cell 
proliferation and ALP activity were higher than on MWCNT. They thought those results 
could be due to the surface topology and chemical properties of the substrates 
2
. However, 
the SWCNT films showed different results to MSC. SWCNT films and carbon fibers 
reduced the metabolic activity of both investigated cell types in different ways, as the 
reduction is more produced for carbon fibers. The high quality SWCNT films are 
apparently not toxic for the MSC under the conditions used. The observed reductions of 
metabolic activities can  be occasioned by the surface morphology of the carbon 
materials 
41
. Park’s results clearly showed that MSC exhibited preferential growth on 
CNT patterns, and the cell culture results suggested that the CNT patterns didn’t have a 
14 
 
 
 
harmful effect on the MSC. Those results investigated CNT patterns have enormous 
potential as a new platform for basic research and applications using stem cells 
42
. 
All those studies discussed above are using pure CNTs, however, reinforcement 
of naturally derived polymers with carbon nanotubes is another promising area that is just 
beginning to be explored. In 2006, Chlopek et al. fabricated MWCNT with polysulfone 
PSU (which is currently used in medicine) and investigated their effect on osteoblast. The 
cellular test performed in this study confirmed a good biocompatibility of nanotubes. 
Like high level of viability of the examined cells in contact with the nanotubes, the 
unchanged level of oteocalcin released from osteoblasts, the lack of proinflammatory IL-
6;these effects point out a good cellular biocompatibility 
43
. Type I collagen is one of the 
most studied molecules in biology because of its very important physical and biochemical 
functions in the extracellular matrix of many tissues, and has shown promise as a matrix 
for regenerative medicine 
44,45
. MacDonald et al. reported a collagen-SWCNT composite 
for the cell culture substrate. The SWCNTs were strongly entrapped by collagen and the 
composite showed high mechanical strength.  And the cell showed good cell viability. 
The affinity between collagen and CNTs was expected 
29
. Recently, Terada et 
al .developed a transparent MWCNTs coating for cell culture dishes and estimated its 
properties for cell culture. In this research, they found rat osteoblast-like cells cultured on 
the MWCNT-coated dish which showed slightly lower viability and proliferation 
compared to the collagen-coated dish. The cell adhesion on the MWCNT coated dish was 
much higher than that on the collagen-coated dish. Therefore, CNT-coating for dishes 
will be a useful new material for cell culture 
46
. However, there is only limit research 
about collagen-CNT composite materials, especially on stem cell research. 
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2.3 Mesenchymal Stem Cells  
It is commonly believed that stem cell is involved in continuous maintenance and 
repair of most tissue types. Taken into consideration that stem cells are capable of self 
renewal and they share the ability to differentiate in multiple lineages. This class of cells 
is of paramount importance for an organism, not only during development, but also 
during adulthood with respect to cellular homeostasis. Stem cells for non-hematopoietic 
tissues, which can be derived from bone marrow are commonly termed mesenchymal 
stem cell (MSC). MSCs are considered a readily accepted source of stem cells because 
such cells have already demonstrated efficacy in multiple types of cellular therapeutic 
strategies, especially in bone tissue regeneration strategies 
47
.  
MSC differentiation, morphology, markers expression and inflammatory response 
The multiline differentiation potential of MSC populations derived from a variety 
of different species has been extensively studied in vitro since their first discovery in the 
1960s 
48
. MSC has the capacity to differentiate into all connective tissue cell types, 
including bone, cartilage, tendon, muscle, marrow, fat and dermis. In vitro studies 
showed successfully differentiation in a variety of cell lineages, including osteoblasts, 
chondrocytes, adipocytees, fibroblasts, myoblasts and cardiomyocytes, hepatocytes, 
tenocytes, cenocytes, and even neurons.
49-52
 
The differentiation can be simulated in vitro by adding the proper differentiating 
supplements to MSC, including dexamethasone (Dex), L-ascorbic acid (L-AA), and β-
glycerophosphate (β-GP), each of them play a unique role in the differentiation 
process.
53-56
 For convenience, the differentiation process of the osteoblast committed 
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MSC is divided into several stages, like osteoprogenitors, preosteoblasts, osteoblastes, 
osteocytes, and bone lining cells (Figure 2.2).  
Osteoprogenitor cells: it is a mainly functionalized cell type. Osteoprogenitors 
are able to clonally generate cells of osteoblast lineage but lack self-renewal capacity 
57
. 
The cell morphology is spindles shaped and reside in close proximity to the preosteoblast 
layer with a distance from bone formation surface in the periosteal layer of bone 
58
. 
Preosteoblasts: this type of cell is considered as a precursor of the oteoblasts and 
indentified in part by their localization in the adjacent one or two cell layers’ distance 
from the osteoblasts lining bone formation surfaces.  Although preosteoblasts resemble 
osteoblasts histologically and stain for ALP acitivity, they have not yet acquired many of 
the other characteristics of fully mature cells, and unlike osteblasts, preosteoblasts are 
thought to possess a limited proliferation potential. 
Osteoblasts: it is a post proliferative, strongly alkaline phosphatase positive cell 
lining bone matrix at sites of active matrix production. This type of cell has a large 
nucleus, enlarged Golgi apparatus, and extensive endoplasmic reticulum, which are 
typical features of cells highly active in protein production.
59
 
Osteocytes: It is a non-proliferative, terminally differentiated cell of the 
osteoblasts lineage. They are non-migratory cells, locked inside small lacunae in the 
mineralized bone matrix or the newly formed osteoid. Compared with mature osteoblasts, 
the osteocytes are smaller and have decreased ALP activity and cytoplasmic organelles. 
However, there is an emerging consensus that osteocytes play an important role in the 
maintenance of bone structure.
60-62
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Bone lining cells: These types of cells are flat, thin and elongated, covering most 
if not all the non-remodeling bone surfaces. Bone lining cells are considered 
postproliferative, inactive in matrix production and may take part in mechanotransduction 
and protection of the bone matrix from osteoclastic resorption.
63
 Another feature of the 
bone lining cells is their potential to be reactivated to cuboidal, which can active 
osteoblasts in response to particular stimuli.
64
 
The cells change dramatically in morphology from their in vivo state. However, 
this compartmentalization is problematic for in vitro studies. Therefore, using molecular 
markers to evaluate the differentiation of MSC is most practical. The MSC differentiation 
is associated with temporal modification in the expression of a set of macromolecules. 
These molecules include membrane-associated enzymes (such as Alkaline phosphatase), 
bone matrix protein (such as type I collagen), and different cytokine receptors. Those 
macromolecules not only play important roles in regulating cell proliferation and function 
but also provide a panel of markers that reflect the transitional stages in osteoblast 
development (Figure 2.3). 
Type I collagen: It is a primary product of osteoblasts during bone matrix 
formation, constituting approximately 90% of the total organic matrix in mature bone 
65
. 
In osteoblast lineage cells, type I collagen is clearly expressed before the preosteoblast 
stage, and it has been documented that up-regulation of type I collagen occurs prior to up-
regulation of any other matrix molecules and prior to ALP.
66
 
Alkaline phosphatase (ALP): Alkaline phosphatase is a hydrolase enzyme 
responsible for removing phosphate groups from many types of molecules, including 
nucleotides, proteins, and alkaloids. It is the most frequently used phenotypic marker to 
18 
 
 
 
evaluate bone activities 
67
. The major role of ALP in bone is to facilitate mineralization. 
It is abundantly presents in membranes of osteoblasts and matrix vesicles when it 
covalent bounds to glycosylphosphatidylinositol (GPI).
68
 In addition, ALP can also be 
detected in subpopulations of osteoprogenitors and preosteoblasts, well before 
mineralization and prior to the expression of the noncollagenous matrix molecules.
69
 That 
is why ALP plays as a membrane-bound receptor involved in osteoprogenitor osteoblast 
adhesion, migration, and differentiation.
70
 
Osteocalcin: Osteocalcin is a carboxylated bone protein also known as bone Gla 
protein. It is the most abundant non-collagenous protein of bone and has a very narrow 
expression pattern. Osteocalcin is undetectable in preosteoblasts and expressed only by 
the mature osteoblasts and osteocytes. Therefore, the latest expressed osteoblast makers 
is osteocaclin.
71,72
  
Interleukin-6 (IL-6): A variety of publications suggest that treating inflamed 
cells with nano-particles decreases the cells’ inflammatory responses.73,74 Cytokine 
expression has been measured for MSC isolated from rat bone; results indicated that MIF, 
IL-8, Serpin E1, GROα, IL-6, MCP-1, and SDF-1 were the most highly expressed 4. IL-6 
is a multifunctional cytokine that can activate target genes involved in proliferation, 
differentiation, survival and apoptosis in a variety of cells.
72,75
  Indeed, researchers have 
shown that the production of interleukin-6 by bone marrow cells is regulated by sex 
steroids.
76-78
 Upon loss of gonadal function, osteoclast and osteoblast formation in the 
marrow increase. Both changes are apparently mediated by increase in the production of 
IL-6.
79
 A pathogenic role for IL-6 and its receptor has been also demonstrated in other 
systemic diseases with increased bone remodeling, such as hyperparathyroidism and 
19 
 
 
 
hyperthyroidism.
80
 IL-6 activates nuclear factor κB (NF-κB) through the mitogen-
activated protein kinase (MAPK) signal transduction pathway, which regulates 
expression of the receptor activator of NF-κB ligand (RANKL).81 through the IL-6-
gp130-STAT3 signaling pathway.
82
 RANKL then binds to receptor activator NF-κB 
(RANK) on the surface of osteoclast progenitor cells, inducing the formation of a mature 
osteoclast.
83
 Therefore, IL-6 cytokines stimulate osteoblast differentiation and bone 
formation. 
 
 
Figure 2.2 1. preosteoblast, 2. preosteoblastic osteoblast, 3. osteoblast, 4. osteoblastic 
osteocyte (Type I preosteocyte), 5. osteoid-osteocyte (Type II preosteocyte), 
6. Type III preosteocyte, 7. young osteocyte, 8. old osteocyte. Diagram 
drawn by Tim Fedak (www.figs.ca).
61
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Figure 2.3 Biomarker produced during different stages of MSC differentiations. 
2.4 Toxicity Assessment of Carbon Nanotubes 
CNTs are useful materials with numerous technological potentials. When CNT 
synthesis moved from laboratories to factories and the products became commercial 
commodities, CNTs began to come under toxicological scrutiny. 
2.4.1 In vivo toxicology studies: rat, pig, fish 
Most of the emerging literatures on the toxicity of CNTs have shown the model of 
respiratory exposure with consequent concerns about lung injury, inflammation and 
possible early signs of tumor formation in the lung (Table 2.2).
84
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Table 2.2 Pulmonary toxicity studies of CNTs in animals 
84
 
Test materials Metal content Animal species References 
 
Soot containing 
CNTs 
Co/Ni 
No info on % 
 
Guinea pig Huczko et al.,2001 
SWCNTs Ni:10% Mouse Lam and 
McCluskey, 2000 
(unpublished report) 
SWCNTs Fe:26.9% 
Mo:0.95% 
Ni:0.8% 
Mouse Lam et al., 2004 
SWCNTs, purified Fe:2.1% Mouse 
 
 
Lam et al., 2004 
SWCNTs Ni:26% 
Y:5.0% 
Fe:0.5% 
Mouse Lam et al., 2004 
SWCNTs Ni:5% 
Co:5% 
Rat 
 
 
Warheit et al., 2004 
SWCNTs, purified Fe:0.23% Mouse 
 
 
Shvedova et al., 
2005 
MWCNT Co:0.95% 
Fe:~1% 
Rat 
 
Muller et al., 2005 
 
The first study of a carbon nanotube product in Chunea pigs conducted by 
Huczko’ et al of Warsaw University was published in 2001.85 The results of this 
exploratory study showed that the intratracheal instillation of fibrous carbon 
nanostructures does not change pulmonary function and does not induce any measurable 
inflammation in bronchoalveolar space in CNTs-exposed guinea pigs. Thus, based on this 
research, they thought working with soot containing carbon nanotubes is unlikely to be 
associated with any health risk.  
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However, after three years, the first study of SWCNT toxicity , in which lung 
histopathology in exposed mice was examined,
86
 was conducted to address NASA’s 
concern that workers in occupational settings could be exposed to the airborne dust of 
this novel materials of unknown toxicity. In Lam, C. W’s study they used three products 
which were made by different methods and contained different types and amounts of 
residual catalytic metals. Mice were intratracheally instilled with 0, 0.1, or 0.5 mg of 
carbon nanotubes, a carbon black negative control, or a quartz positive control, and then 
they were euthanized 7 days or 90 days after the single treatment for a histopathological 
study of the lungs. All nanotube products induced dose-dependent epithelioid granulomas 
and, in some cases, interstitial inflammation in the animals of the 7 days groups. These 
lesions persisted and were more pronounced in the 90 days groups; the lungs of some 
animals also revealed peribronchial inflammation and necrosis that had extended into the 
alveolar septa. The lungs of mice treated with carbon black were normal, whereas those 
treated with high-dose quartz revealed mild to moderate inflammation. These results 
show that, for the test conditions described here and on an equal-weight basis, if carbon 
nanotubes reach the lungs, they were much more toxic than carbon black and can be more 
toxic than quartz, which is considered a serious occupational health hazard in chronic 
inhalation exposures. 
Not only in the mouse, Warheit and his research group of Du Pont Company also 
conducted toxicity study in rats of a SWCNTs product made by their company.
87
  In this 
study the lungs of rats were instilled either with 1 or 5 mg/kg of the SWCNT, quartz 
particles (positive control), carbonyl iron particles (negative control), phosphate-buffered 
saline (PBS) + 1% Tween 80, and graphite particles (lung tissue studies only). Following 
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exposures, results from the lung histopathology component of the study indicated that 
pulmonary exposures to quartz particles (5mg/kg) produced dose-dependent 
inflammatory responses, concomitant with foamy alveolar macrophage accumulation and 
lung tissue thickening at the sites of normal particle deposition. Pulmonary exposures to 
carbonyl iron or graphite particles produced no significant adverse effects. Pulmonary 
exposures to SWCNTs in rats produced a non-dose-dependent series of multifocal 
granulomas, which were evidence of a foreign tissue body reaction and were nonuniform 
in distribution and not progressive beyond 1 month post exposure. The physiological 
relevance of SWCNT-induced multifocal granulomas findings should ultimately be 
determined by conducting an inhalation toxicity study. MWCNTs have been shown to 
produce lung lesions similar to those observed in studies with SWCNTs. The Muller’s 
research group tested two forms of MWCNTs, and they found that 60 days after rats were 
each given a single ITI does of 0.5, 2, or 5mg MWCNT, their lungs showed inflammation, 
granulomas, and fibrosis.
88
 
The concerns about the toxicity of carbon nanotubes on mammalian studies have 
increased, and there is even one article showing the toxicity of SWCNT on aquatic life 
using rainbow trout.
89
 They used a semi-static test system to expose rainbow trout to a 
freshwater control, solvent control, 0.1, 0.25 or 0.5 mg/L SWCNT for up to 10 days. 
From this study they found that SWCNTs are respiratory toxicant in trout.the fish were 
able to manage oxidative stress and osmoregulatory disturbances, but other cellular 
pathologies raised concerns about cell cycle defects, neurotoxicity, and some unidentified 
blood borne factors that possibly mediate systemic psthologies. 
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2.3.2 In vitro toxicology studies 
Human exposure to nanoparticles in the air is a complex process. Particle sizes 
can range from individual particles of around 50 nm or much less in vehicle exhausts.
90
 
The growth of larger aggregates of particles is associated with coagulation or 
condensation processes in the urban air 
91
. Another approach used in toxicological 
investigations is to study the responses of individual cell types with a view of obtaining 
evidence on the mechanisms of toxicity.  Toxicological studies are assessing respiratory 
exposure of nanoparticles in vitro. These raise some concerns for health effects, but 
without measurements of manufactured nanoparticles in the atmosphere, it is difficult to 
precisely quantify the current risk to the general public. That is why many researchers 
tried the different dose and exposure time of CNT on different cells.  Several in vitro 
assessments of the toxicity effects of manufactured nanomaterials have been carried out 
(Table 2.3). 
Overall, these studies suggest that oxidative stress is one possible mechanism of 
toxicity. This may be also linked to inflammation responses. Shvedova et al.
94 
showed 
that SWCNT cause oxidative stress and cellular toxicity to HEK. There are also results 
that come from skin cell culture,
94
 like Monteiro-Riviere et al. found that MWCNT 
caused a time dependent release of the pro-inflammatory cytokine, Interleukin 8 (IL-8),
93
 
from human epidermal keratinocytes. Other toxicity effects at the cellular level include 
changes in cell growth and turnover. In Cui et al.
92 
study they found the inhibition of 
HEK 293 cell proliferation, induced cell apoptosis, and decreased cellular adhesive 
ability. 
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Table 2.3 Examples of the toxic effects of CNTs from in vitro studies 
 
Nanomaterial Dose/Exposure time Cells Study  
 
SWCNT Serial dilutions from 
0.78 to 200ug/ml 
Human HEK 293 
(human embryo 
kidney) cells 
Cui  et al. 2005 
92
 
MWCNT Serial dilutions of 
0.2-0.1 mg/ml for 1, 
2, 4, 8, 12, 24 and 48 
hour 
Human epidermal 
keratinocytes (HEK) 
Monteiro-Riviere et 
al. 2005 
93
 
SWCNT 0.06-0.24mg/ml for 
up to 18 hour 
HEK cells in culture Shvedova et al. 2003 
94
 
SWCNT 0, 400,800 μg/ml 
For 24 hour 
A549 cell Davoren et al. 2007 
95
 
SWCNT 30 and 60 μg/ml for 
1, 24 and 48 hour 
Human macrophage 
cells 
Fiorito et al. 2006 
96
 
SWCNT 1mg/ml for 4 days Human epithelial-like 
Hela cells 
Yehia et al. 2007 
97
 
 
  The lungs as a whole have been subjected to testing for the potential hazards of 
inhalation exposure to carbon nanotubes. The cytotoxicity effect of CNTs has been 
evaluated in vitro on culturing lung cells. Kisin et al. 
98
 have reported loss of viability in 
lung fibroblast cell line in a concentration and time dependent manner after the exposure 
of cells to SWCNT.  The serum supplementation to the cell culture medium probably 
made the CNT non toxic, as demonstrated by Yehia et al.
97 
Human epithelial-like lung 
cell line (A549) has been widely used in the in vitro cytotoxicity assessment of SWCNT. 
Maria Davoren’s95 study revealed that the SWCNT have low acute toxicity after exposure 
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of A549 cells to a wide dose range of SWCNT (1.56-800 ug/ml) for 24 hours. And in this 
study, they found greater SWCNT toxicity was observed in absence of serum.  Casey et 
al.
99
 demonstrated that the cause of cytotoxicity to the A549 cells to be due to media 
constituent depletion and referred to it as a case of false positive result. On the other hand, 
some studies showed the effect of the CNTs to A549 cells. For example , the research 
group in Korea found little cytotoxic effects on the proliferation and viability of A549 
and other three cell lines expose to the SWCNT concentrations (<250-500ug/ml) within 
48 hours. However, exposing A549 cells to high SWCNT concentrations (250-500ug/ml) 
for 72 hours resulted in an inflammatory response with oxidative stress and membrane 
damage 
100
. Herzog et al. showed that exposing A549 cells to SWCNT samples can lead 
to the suppression of a variety of inflammatory mediators including IL-8, IL-6 and MCP-
1 in vitro 
101
. At the same time, researchers demonstrated that MWCNTs are able to 
induce inflammatory responses in vitro. Oxidative stress and NF-κB activation seem to 
play an important role in MWCNTs-induced cytokine production, which suggests that 
MWCNTs exert proinflammatory effects by a mechanism that is mediated by ROS and 
NF-κB 102. 
Despite these details on effects in cell culturesand respiratory effects in vitro, our 
knowledge on CNTs toxicity is incomplete. Some results indicated CNTs to be highly 
toxic 
77,103-105
, and others showed low toxicity or no signs of toxicity at all 
106-108
. In 
addition, many of these experiments used a “proof of principle” approach using relatively 
high doses to ensure a clear demonstration of toxicity effect. However, these types of 
experiments do not generally give data on “no effect” levels that are of interest in risk 
assessment. More detailed studies are needed. 
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CHAPTER 3 
CARBON NANOTUBE-COLLAGEN SCAFFOLDS FOR MESENCHYMAL 
STEM CELLS’ DIFFERENTIATION: CHANGES IN ALKALINE 
PHOSPHATASE EXPRESSION AND MINERALIZATION 
3.1 Abstract 
Studies of the application of carbon nanotubes (CNTs) have been carried out for 
the substrates of cell culture, drug delivery systems, and medical implant materials. 
However, little is known about the impact of CNTs on cellular processes such as 
adhesion, proliferation, and differentiation. We hypothesized that augmenting the 
properties of naturally derived polymers (collagen, in this study) through the 
incorporation of CNTs might enhance osteogenic differentiation of MSCs in vitro. In this 
study, we incorporated different concentrations and types of multi-walled CNTs 
(MWCNTs) into reconstituted type I collagen, and evaluated proliferation, differentiation, 
mineralization, and inflammatory response of mesenchymal stem cells (MSCs) on these 
MWCNT-collagen scaffolds. MWCNTs were distributed in collagen matrix, and strongly 
entrapped in collagen at the concentrations below 100 ppm. Alkaline phosphatase (AP) 
activity and mineralized nodules of extracellular matrix (ECM) were monitored as 
osteogenic differentiation markers. Collagen itself enhanced MSCs differentiation and 
mineralization due to its nanoscale feature. MWCNTs added to collagen scaffolds 
induced an additional increase in MSCs differentiation and mineralization. MWCNT-
collagen scaffolds induced significantly higher level of AP activity than plastic surface 
and increased ECM mineralization 12 days after replacement with differentiating media. 
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Additional increase in MSC differentiation and mineralization may be due to the 
increased stiffness and tensile strength of MWCNT-collagen scaffolds. 
3.2 Introduction 
There have been significant advances in cell-based therapy and tissue engineering 
for the repair and replacement of damaged tissues and organs. Nanotechnology has 
emerged showing great potential for the creation of the next generation of materials. 
Recent researches have more focused on the role of nano-structure and nano-scale 
materials for tissue engineering applications.
1
 Carbon nanotubes (CNTs) were first 
introduced by Oberlin et al. in 1976
2
 and their development and applications have been 
dramatically increasing in biosensors, tissue engineering, and biomedical devices, 
because of their unique electronic, chemical and mechanical properties
3-6
. Studies of the 
application of carbon nanomaterials have been carried for the substrate of cell culture
7-9
, 
drug delivery systems,
10,11
 and medical implant materials. The applications of CNTs have 
tremendous potentials for them as substrates of cell cultures, drug delivery systems, and 
medical implantable materials.
10-13
 Nanomaterial-based scaffolds can provide many 
critical features of the microenvironments for cell adhesion, proliferation, and 
differentiation. However, little is known about the impact of CNTs on cellular processes 
such as adhesion, proliferation, and differentiation. Nanomaterial-based scaffolds can 
provide many critical features of the microenvironments for cell adhesion, proliferation, 
and differentiation. 
A variety of new approaches and new materials have been developed for creating 
improved scaffolds with engineered tissues.
14,15
 The advent of the field of 
nanotechnology has stimulated an interest in creating nanocomposite materials for a 
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variety of purposes, including biomedical applications. Initial studies using composites of 
synthetic polymers and CNTs have demonstrated promise for these materials in neural 
and orthopedic tissue engineering applications. The reinforcement of naturally derived 
polymers (e.g. ECM) with carbon nanotubes has been attempted to compensate for ECM 
scaffold limitations such as weak mechanical properties, lack of electrical conductivity, 
the absence of adhesive and microenvironment-defining moieties.
16
 CNTs have diameters 
ranging from 0.7 to 2.0 nm (typically around 1.0 nm), with the lengths that are often 
hundreds or thousands of times greater than their diameter.
17
 This high aspect ratio of 
CNTs plays an important role as in fiber-reinforced composite materials additives.
18
 
CNTs has similar viscoelastic property to that observed in soft-tissue membrane, so they 
have been used to icrease the Yong’s modulus and tensile strength of the hybrid 
biomaterials.
16,19,20
 
In this study, we used MWCNT-reinforced collagen scaffolds to investigate the 
osteogenic differentiation of MSCs. The overall goal is to develop scaffolds that provide 
enhanced mechanical and functional properties in a variety of tissue engineering 
applications, by augmenting the properties of naturally derived polymers through 
incorporation of carbon nanotubes. Our study was spurred by the following questions: 1) 
How CNT-based materials affect cellular processes (e.g. renewal, metabolic activity, and 
differentiation) of MSCs? 2) Does this addition of CNTs into naturally derived polymers 
result in creating stiffer environment in which osteoprogenitor cells may prefer to be 
differentiated into osteocytes?  To address the above issues, we incorporated different 
concentrations and types of multi-walled CNTs (MWCNTs) into reconstituted type I 
collagen, and evaluated proliferation, differentiation, mineralization, and inflammatory 
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response of mesenchymal stem cells (MSCs) on these MWCNT-collagen scaffolds. 
Alkaline phosphatase (AP) activity and mineralized nodules of extracellular matrix (ECM) 
were monitored as osteogenic differentiation markers. Collagen itself enhanced MSCs 
differentiation and mineralization due to its nanoscale feature. MWCNTs added to 
collagen scaffolds induced an additional increase in MSCs differentiation and 
mineralization. MWCNT-collagen scaffolds induced significantly higher level of AP 
activity than plastic surface and increased ECM mineralization 12 days after replacement 
with differentiating media. Additional increase in MSC differentiation and mineralization 
may be due to the increased stiffness and tensile strength of MWCNT-collagen scaffolds. 
3.3 Materials and Methods 
3.3.1Materials and Reagents 
HiPco derived MWCNT, MWCNT-OH and MWCNT-COOH were purchased 
from Cheap Tubes Inc (Brattleboro, VT). Rat tail collagen type I was purchased from BD 
bioscience (Rockville, MD). Alamar Blue™, Quant-iT™ PicoGreen® dsDNA detection 
kit, and rat interleukin 6 (IL-6) CytoSet™ was purchased from Invitrogen Corporation 
(Carlsbad, CA).  
3.3.2 Isolation and Culture of rat MSCs 
The rat femurs were removed under aseptic conditions and the connective tissue 
was excised. The epiphyses were removed from the femurs and the cavity was washed 
twice with phosphate buffered saline (PBS) solution with 1% penicillin/streptomycin to 
isolate bone marrow. The solution was centrifuged at 1000 rpm for 10 minutes, and the 
PBS was extracted. The MSCs were resuspended in Dulbecco’s Modified Eagle’s 
40 
 
 
 
Medium (DMEM) with other supplements: 10% fetal bovine serum (FBS), 5 ml of 
penicillin/streptomycin, and 1 ml of amfotericin. Most of MSCs were at or between 
osteoprogenitor and pre-osteoblast stage. The MSCs were seeded at a density of 4×10
4
 
cells/well on MWCNT-collagen scaffolds and incubated at 37°C and 5% CO2. The MSCs 
can be differentiated to the osteoblastic phenotype by the addition of 10 mM of β-
glycerophosphate, 50 μg/ml of ascorbic acid, and 10 nM of dexamethasone.  
3.3.3 Dispersion of MWCNTs 
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs 
(20 - 30 nm in diameter) with two different length (long; 10- - 2.0 
and sonicated for 10 minutes with a 10 second cooling 
time per 1 minute sonication cycle using a Sonicator 3000 manufactured by Misonix 
(Farmingdale, NY). After sonication, a nontoxic surfactant polyvinylpyrrolidone (PVP) 
(Fisher Scientific, PA) was added to the SWCNT solution to inhibit the aggregation of 
MWCNTs in the solution. 
3.3.4 Preparation of MWCNT-collagen scaffolds 
Different concentrations (10, 50, 100, and 855 ppm) of MWCNTs was formulated 
into a fixed concentration of collagen type I (1 mg/ml) with 10% NaHCO3. 1000 µl of 
MWCNT-collagen mixture were transferred to each well of 24 well plates, and cell 
incubated for 30mins at 37 
o
C.  
3.3.5 Cell viability assay 
The Alamar blue assay (Biosource International, Camarillo, CA, USA) is 
designed for the measurement of cell viability. It incorporates a fluorometric indicator 
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based on detection of metabolic activity. The oxidized form of Alamar blue (AB), which 
has little intrinsic fluorescence, becomes reduced in viable cells, and the reduced form of 
the AB is highly fluorescent. The viability of the cells can be quantified by the extent of 
this conversion 
21
. As negative control, AB was added to the medium without cells. The 
plate was further incubated for 1hour at 37.0 
0
C. To examine cell viability, MSCs were 
loaded with Alamar blue at the final concentration of 10%. Under each experiment, 
fluorescence of Alamar blue was measured on three separate cell monolayers at an 
excitation wavelength of 545 nm and an emission wavelength of 590 nm by a 
fluorescence microplate reader (Synergy HT Multi-Mode Microplate Reader, Bio-Tek). 
The cell viability was calculated as the ration of fluorescence intensity in treated to 
untreated cells.  
3.3.6 Quantification of DNA contents 
The Quant-iT PicoGreen assay is a method used to quantify DNA. It is a 
nonspecific method that relies strictly on the total amount of DNA present rather than the 
presence of a specific gene. Briefly, cells were washed once with phosphate-buffered 
saline (PBS) after removal of culture medium andlysed in 200 ml of 25mM Tris/0.5% 
Triton X-100 (pH 8) solution followed by three freeze/thaw cycles. Quantification of 
DNA contents was conducted according the manufacturer's instructions (Molecular Probe, 
TX). Fluorescence intensity was measured at an excitation wavelength of 480 nm and an 
emission wavelength of 520 nm by a fluorescence microplate reader (Synergy HT Multi-
Mode Microplate Reader, Bio-Tek).  
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3.3.7 Alkaline phosphatase (AP) activity 
The alkaline phosphatase (AP) detection is designed for the measurement of cell 
differentiation.Calf intestinal alkaline phosphatase (CIAP) for AP Detection was 
purchased from Promega (Madison, WI). The substrate (0.4mM of CSPD with Sapphire 
II, CD100RX) for AP was purchased from Applied Biosystems (Carlsbad, CA). 
Preparation method of cell lysates was same as a quantification method of DNA contents. 
Chemiluminescence of AP activity in each sample was detected by a chemiluminrscence 
microplate reader (Synergy HT Multi-Mode Microplate Reader, Bio-Tek). The light 
output from each sample was integrated for 10 seconds after a 2 second delay. 
Chemiluminescence data were calibrated with a CIAP standard curve to present AP 
activity. 
3.3.8 Interleukin 6 expression 
Levels of IL-6 were determined by specific sandwich ELISAs, according to the 
manufacturer’s instructions. IL-8 human antibody pair and buffer kit were purchased 
from Invitrogen (Carlsbad, CA). 
3.3.9 Von Kossa Staining 
The cell cultures were washed twice with PBS, fixed in phosphate buffered 
formalin for 10 min, washed once with de-ionized water, and serially dehydrated in 70%, 
95%, and 100% ethanol two times and dried. The cells were then rehydrated in 100%, 
95%, 80% EtOH, and de-ionized water. After addition of 5% silver nitrate solution, the 
wells were exposed to sunlight for 20 minutes (or light for 2 h) after which the plate was 
rinsed with water. After addition of sodium thiosulfate (5%) for 3 minutes, the cells were 
then rinsed in water. Acid fuchsin counterstain (5 ml of 1% acid fuchsin + 95 ml of picric 
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acid + 0.25 ml of 12N HCL) was added to cell layers for 5 minutes. The cells were 
washed with de-ionized water, twice with 95% EtOH, twice with 100% EtOH, and dried 
for image analysis .The number of mineraized nodules was quantified using a 10 X 
objective.
22
 
3.3.10 Measurement of mechanical and surface  
            property of MWCNT-collagen scaffolds 
The surface properties of MWCNT-collagen scaffolds were  investigated by water 
contact angle (WCA) measurement. A 2 μL water droplet was dripped on the dried 
surface of a MWCNT-collagen scaffold. The image was captured 6 seconds after the 
water droplet was dripped on the surface. Contact angles (left and right) were measured 
by an optical contact angle meter (VCA Optima, AST products Inc.).  
Compressive testing was performed on MWCNT-collagen scaffolds in wells of a 
24 well plate. The height of each sample from the bottom of the well was approximately 
5 mm, and the surface are of the bottom of the well was 1.9    . The diameter of the 
probe that was used was 10 mm. The test was performed at and extension rate of 10 
mm/min until failure was reached, using an Instron 5542 apparatus (Instron, Norwood, 
MA). Yong modulus was determined from the elastic regime slope of stress–strain curves 
(<40% strain). 
3.3.11 Statistical Analysis 
Statistically significant differences were set p≤ 0.05. Statistically significant 
differences were set p≤ 0.05. Statistical analyses were carried out using one-way analyses 
of variance (ANOVA) followed by Dunnett’s multiple comparison tests. 
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3.4 Results 
3.4.1 Effect of concentration of MWCNTs on  
        MSC’ differentiation in MWCNT-collagen scaffolds 
Different concentrations of MWCNTs were added to collagen scaffolds. MSCs 
were seeded onto the MWCNT-collagen scaffolds. When MSCs reach confluence, the 
cell culture media was replaced with differentiating media. AP activity was measured at 
four day interval. Collagen itself enhanced MSCs differentiation. MWCNTs added to 
collagen scaffolds induced an additional increase in MSCs differentiation. MWCNT-
collagen scaffolds induced significantly higher level of AP activity than plastic surface 12 
days after replacement with differentiating media. MWCNT-Collagen scaffold-induced 
AP activities were not dose dependent (Figure 3.1).  Although AP levels were higher in 
MWCNT-scaffolds at all concentrations of MWCNTs, transparency of the scaffolds 
reduced as the concentrations of MWCNTs increased (Figure 3.2). Transparency of the 
MWCNT-collagen scaffolds was good at lower MWCNT concentrations (<100ppm of 
MWCNTs), but was significantly reduced at higher MWCNT concentrations (>100 ppm 
of MWCNTs).  
3.4.2 Effects of different types of MWCNT-collagen 
         scaffolds on MSC’ differentiation 
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs 
with two different length were added to collagen scaffolds at 10 ppm of MWCNTs.  
When MSCs reach confluence, the cell culture media was replaced with differentiating 
media. AP activity was measured at four day interval. AP activity increased as the cells 
were differentiated on all different types of MWCNT-collagen scaffolds. The level of AP 
activity of MSCs was higher on all different types of MWCNT-collagen scaffolds. At the 
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day 12, all types of MWCNT-collagen scaffolds induced the higher level of MSC 
differentiation, compared to the plastic surface and collagen controls (# p<0.05) (Figure 
3.3).  However, different types of MWCNTs did not show significantly differences in AP 
activity on MWCNT-collagen scaffolds.  
3.4.3 Effects of different types of MWCNT-collagen  
         scaffolds on the formation of mineralized matrix nodules 
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of MWCNTs 
with two different length were added to collagen scaffolds at 10 ppm of MWCNTs. 
When MSCs reach confluence, the cell culture media was replaced with differentiating 
media. As the days increased, MSCs induced the increased mineralized nodules. The area 
of mineralized matrix nodules was significantly higher at day 15 (Figure 3.4).  Especially, 
MSCs on both MWCNT-collagen (short) and MWCNT-OH-collagen (short) scaffolds 
induced significant increase in mineralization of matrix nodules (Figure 3.4).    
3.4.4 Effects of MWCNT-collagen scaffolds on  
         cell viability and cell proliferation 
There was no significant change in cell viability among different types of 
MWCNT-collagen. Significant decrease in cell viability on MWCNT-collagen scaffolds 
was observed only at day 4 (Figure 3.5A). All types of MWCNT-collagen scaffolds did 
not induce a detrimental effect on cell proliferation (Figure 3.5B). In most cases, cell 
proliferation was increased during this period.  
3.4.5 Effects of MWCNT-collagen scaffolds on inflammatory response 
The levels of IL-6 expression did not change significantly as the days increased. 
However, IL-6 levels were significantly lower on all types of functionalized MWCNT-
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collagen scaffolds, except MWCNT (long)-collagen scaffolds,  than plastic surfaces 
(Figure 3.6) (# p<0.05).  
3.4.6 Mechanical properties of MWCNT-collagen scaffolds 
Contact angles of collagen scaffolds are higher than those of plastic surface, but 
they are not significantly different. There was no significant difference in contact angles 
among different types of MWCNT-collagen scaffolds (Figure 3.7). The elastic modulus 
increases with the addition of MWCNTs to the collagen gels. The stiffness was varied as 
we increased the concentrations of MWCNTs in collagen scaffolds.  50 ppm of 
MWCNTs in MWCNT-collagen scaffolds showed significantly higher stiffness than 
others (Figure 3.8). 
3.5 Discussion 
All cells or tissues are exposed to the specific microenvironments that are 
generated locally at the micro- or nano-scale level by cell–cell, cell-soluble factor, or 
cell–extracellular matrix interactions and that influences cell functions in their tissues. 
Especially, each cell type is specifically tuned to the specific microenvironments in 
which it resides. For example, the brain tissues are softer than bone tissues. Consequently, 
neural cell growth, survival and differentiation are favored by a highly compliant matrix. 
By contrast, osteoblast differentiation and survival occurs preferentially on stiffer 
extracellular matrices with material properties more similar to newly formed bone 
23
. 
ECM or ECM-like structure can create cellular microenvironment for specific cells or 
tissues. In addition to creating cellular microenvironment using ECMs, nanomaterials can 
be used to compensate for ECM scaffold limitations such as weak mechanical properties, 
lack of electrical conductivity, and the absence of microenvironment-defining moieties.
16
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We hypothesized that augmenting the properties of naturally derived polymers (collagen, 
in this study) through incorporation of MWCNTs might enhance in vitro osteogenic 
differentiation and mineralization of MSCs. 
In our study, MWCNTs were distributed in collagen matrix, and strongly 
entrapped in collagen (1 mg/ml) at the concentrations below 100 ppm. At these 
concentrations (0 - 100ppm), MWCNT-collagen scaffolds showed excellent transparency, 
which is appropriate for cell culture and microscopic observation (Figure 3.1). MSCs 
were used to mimic the subsequent stages of osteoblastic differentiation in vitro. In the 
initial phases of differentiation process, the undifferentiated MSCs became committed 
and started to proliferate to osteoprogenitors and pre-osteoblasts subsequently. After we 
changed with the differentiating media after 4 days culture in 48well plate on those 
scaffolds, pre-osteoblasts were matured into osteoblasts. During this process, matrix was 
matured, AP (Figures 3.1 and 3.3) and collagen I were released. Subsequently, cells 
started to mature the extracellular matrix and mineralized matrix nodules appeared 
(Figure 3.4). Higher level of AP was released from MSCs on MWCNT-collagen 
scaffolds and collagen than plastic surface (Figure 3.1). The levels of AP were higher on 
all different types of MWCNT-collagen scaffolds than collagen and plastic surface 
(Figure 3.3). In addition, MSCs on both MWCNT-collagens (short) and MWCNT-OH-
collagen (short) scaffolds induced significant increase in mineralization of matrix nodules 
(Figure 3.4).   
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Figure 3.1 Effect of concentration of MWCNTs on MSCs’ differentiation in MWCNT-
collagen scaffolds. Different concentrations of MWCNTs were added to 
collagen scaffolds. MSCs were seeded onto the MWCNT-collagen scaffolds. 
When MSCs reach confluence, the cell culture media was replaced with 
differentiating media. AP activity was measured at four day interval. * 
denotes a significantly higher difference than the control (0 hour) (p<0.05). # 
denotes significantly higher difference than both plastic and collagen control 
at the same time point (p<0.05).  
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Figure 3.2 Transparency of collagen, collagen0 MWCNT composite materials coated 
dishes. This shows a comparison of the color and the transparency of the 
collagen-coated dish and the MWCNT-collagen coated dish. The MWCNT-
collagen coated dish looked slightly gray but had good transparency. 
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Figure 3.3 AP activity of MSC cultured on the different types of MWCNT-collagen 
scaffolds at 0, 4, 8, and 12 days. * denotes a significantly higher difference 
than control (day 0) (p<0.05). # denotes a significantly higher difference than 
the plastic and collagen control at the same time point (p<0.05). MWCNT 
(L): MWCNT-collagen scaffold (long). MWCNT (S): MWCNT -collagen 
scaffold (short).  All types of MWCNT concentration in scaffolds were 
10ppm.     
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Figure 3.4 Von Kossa staining of MSC cultured on different cell culture matrixes. 
Quantification of nodular von Kossa staining using image analysis in the 
same experiment. * denotes a significantly higher difference than day 5 
control (p<0.05).  # denotes a significantly higher difference than the same 
time point plastic scaffolds control (p<0.05). All types of MWCNT 
concentration in scaffolds were 10ppm.     
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Figure 3.5 Effects of MWCNTs on cell viability and cell proliferation on MWCNT-
collagen scaffolds. Three different types (MWCNT, MWCNT-OH,  
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Figure 3.5 (continued) 
                   MWCNT-COOH) of MWCNTs (20 - 30 nm in diameter) with two different 
length (long; 10-20 nm and short; 0.5 - 2.0 nm) were added to collagen 
scaffolds at 10 ppm of MWCNTs. When MSCs reach confluence, the cell 
culture media was replaced with differentiating media. Cell viability and cell 
proliferation were measured after replacement of differentiating media. * 
denotes a significantly higher difference than the control (day 0) (p < 0.05).  
# denotes a significantly higher difference than the plastic control at the same 
time point (p<0.05).  
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Figure 3.6  IL-6 expressions from MSC on different types of MWCNT-collagen 
scaffolds. Effects of MWCNT-collagen scaffolds on inflammatory response. 
Three different types (MWCNT, MWCNT-OH, MWCNT-COOH) of 
MWCNTs (20 - 30 nm in diameter) with two different length (long; 10-20 
ort; 0.5 - 2.0 nm) were added to collagen scaffolds at 10 ppm of 
MWCNTs. When MSCs reach confluence, the cell culture media was 
replaced with differentiating media. IL-6 expresion was measured at four 
day interval after replacement of differentiating media. # denotes a 
significantly lower difference than the plastic control at the same time point 
(p<0.05). 
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Figure 3.7 Contact angle measurements on various MWCNT-collagen scaffolds. The   
water ability of the surface was investigated by water contact angle (WCA) 
measurement. The testing was measured by using a 2 μL water droplet on the 
surfaces under ambient conditions with an optical contact angle meter. The 
image was captured at 6 s after the water droplet was dripped on the surface.  
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Figure 3.8 Measurements of elastic modulus in collagen gels with varying MWCNT-
COOH concentration. Compressive testing was performed on MWCNT-
collagen scaffolds (191mm
2
) at 10 mm/min until failure was reached, using 
an Instron 5542 apparatus (Instron, Norwood, MA). Yong modulus was 
determined from the elastic regime slope of stress–strain curves (<40% 
strain). # denotes a significant difference in elastic modulus from the pure 
collagen gel. 
Structurally, collagen provides tensile strength to tissues via its hierarchical 
assembly of collagen subunits. However, in addition to biologic signaling and 
macroscopic mechanical properties, collagen also possesses nano-scaled features that are 
mediators of cell activity. Previous studies have shown that changes made to certain 
features, such as structural curvature of the collagen fibrils, can regulate the activities of 
adherent cells. Nano-structure and nano-scale materials play important roles in tissue 
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engineering applications. CNTs have been used to modulate cell behavior through their 
electrical conductivity, and mechanically to reinforce or tailor the structural properties of 
tissue engineered scaffolds. In addition, CNTs have been used to increase the surface 
roughness and surface area of scaffolds for cell adhesion.
1
 In this study, collagen itself 
enhanced MSCs differentiation and mineralization due to its nano-scaled feature. 
MWCNTs added to collagen scaffolds induced an additional increase in MSCs 
differentiation and mineralization. Additional increase in MSC differentiation and 
mineralization may be due to the increased stiffness and tensile strength of MWCNT-
collagen scaffolds (Figure 3.8). However, it is still not clear that surface properties of 
MWCNT-collagen scaffolds affect MSC differentiation and mineralization in this study. 
Collagen scaffolds with functionalized MWCNTs (-COOH and -OH) induced 
significantly lower level of IL-6 than other scaffolds and plastic surface. Additional 
surface analysis and different methods for incorporating nanomaterials will be required to 
verify whether surface properties of nanocomposite scaffolds increase or decrease 
inflammatory response as well as cell differentiation.  Future strategies could involve 
incorporating nanoscale materials inside or on the outer surfaces of 3D scaffolds to 
investigate mechanical property-dependent changes in cellular processes. A more 
complete and fundamental understanding of cellular micro-biomechanics and its 
relationship to MSC proliferation and differentiation will be a critical element for the 
development of functional tissues in vitro.  
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CHAPTER 4 
EFFECT OF EXPOSURE CONDITIONS ON SWCNT-INDUCED 
INFLAMMATORY RESPONSE IN HUMAN ALVEOLAR EPITHELIAL CELLS 
4.1 Abstract 
There has been an increasing interest in the development and applications of 
carbon nanotubes (CNTs) due to their huge potential in industrial and medical 
applications, but the toxicological properties of these materials have not been well 
characterized, especially the effects of nanoparticle exposure under different conditions 
on cellular responses. Nano-structured particles are potentially hazardous when they 
deposit in the respiratory system. In this study, we characterized the effects of single 
walled CNT (SWCNT) exposure on interleukin-8 (IL-8) expression in human alveolar 
epithelial cells (A549) under various exposure conditions. We measured the level of IL-8 
expression in the presence and absence of serum following exposure of SWCNTs. The 
results demonstrated that IL-8 expression was enhanced in the presence of serum. When 
A549 cells were exposed to low concentrations of SWCNTs, IL-8 expression kept 
increasing, even after removal of SWCNTs from the media. In addition, SWCNT 
exposure under dynamic cell growth condition induced changes in IL-8 expression.                
4.2 Introduction 
Nanotechnology has the tremendous potential to improve the effectiveness of a 
number of industrial products and could have a substantial impact on the development of 
new products in all sectors, ranging from disease diagnosis and treatments to 
environmental remediation 
1,2
. Nanotechnology is anticipated to become the strategic and 
dominating science and engineering field of the 21
st
 century. Based on this expectation, 
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the U.S. President and the National Science and Technology Council to promote 
nanotechnology and to predict that it would lead the United States to the next industrial 
revolution.
3
 Since the discovery of the carbon nanotubes (CNTs) in 1991,
4
 there has been 
an increasing interest in these materials because of  their huge potential in industrial and 
medical applications. CNTs have been widely used in polymer nanocomposites,
5
 
biomedical applications,
6-9
 and electronics
10
 due to their physical, chemical, thermal and 
optical properties.
11
  Consequently, the size of the global market for CNTs has 
dramatically increased.
12
 However, any potentially adverse effects of CNTs have not 
been well characterized, especially in the lungs and skin, which are regarded as the most 
likely exposure sites during manufacture and material handling.
13-19
 Possible exposure 
conditions of CNTs and their adverse effects will vary among application types and 
environments.  
Animal studies with engineered nanoparticles have shown some adverse effects 
on the lung (e.g., pulmonary inflammation and progressive fibrosis)
3,20,21
 and 
cardiovascular systems (e.g., inflammation, blood platelet activation, plaque formation, 
and thrombosis).
22-24
 Other studies have suggested that discrete nanoparticles may enter 
the bloodstream from the lungs and translocate to other organs such as the brain, through 
the olfactory nerve.
16,25,26
  In vitro studies demonstrated that highly purified single walled 
carbon nanotubes (SWCNTs) induced the release of inflammatory makers such as nitric 
oxide and Interleukin-8 (IL-8).
21,27-34
 Casey and co-workers also demonstrated the 
possible effect of media components on SECNT-induced cellular responses.
35
 The 
interactions among SWCNTs, media components, and cells may affect cell viability, 
cellular inflammatory responses, and other toxicological responses. However, the 
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mechanisms of these interactions have not been well characterized. In addition, most 
cases of in vivo and in vitro studies involved high concentrations of SWCNTs (50~ 800 
µg/ml) and extended exposure times (>24 hours).
31,33,36,37
 
This study was spurred by the following fundamental questions: 1) What other 
environmental factors may affect the nanoparticle-related inflammatory responses or lead 
to cellular toxicity? 2) Are these additional factors related to the translocation of 
nanoparticles? 3) Is the nanoparticle-induced inflammatory response alleviated by 
removing nanoparticles following exposure? In this study, we monitored the SWCNT-
induced IL-8 expression as an inflammatory markers under different exposure conditions, 
including concentrations, exposure times, and the presence of serum.  We also measured 
the SWCNT-induced IL-8 expression in static and dynamic cell growth conditions. 
SWCNT-induced IL-8 expression was enhanced in the presence of serum and kept 
increasing after removal of SWCNTs, especially following exposure to low 
concentrations of SWCNTs. In addition, cellular exposure to SWCNTs in a dynamic cell 
growth condition changed IL-8 expression and cell proliferation. 
4.3 Materials and Methods 
4.3.1 Materials and Reagents 
HiPco derived SWCNTs were purchased from Cheap Tubes Inc. (Brattleboro, 
VT). The Pierce bicinchoninic acid (BCA) protein assay kit was obtained from Thermo 
Fisher Scientific (Rockford, IL). The Human IL-8 CytoSetTM was obtained from 
Invitrogen Corporation (Carlsbad, CA). 
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4.3.2 Cell Culture 
A549 (human alveolar epithelial cells), a human lung adenocarcinoma with the 
alveolar type II phenotype, were obtained from the American Type Culture Collection 
(ATCC, Manassas, VA). Cells were maintained in T-75 culture flasks in a humidified 
incubator at 37
o
C with 5%  CO2 and 95% air, and grown to confluence for 2-3 days in F-
12K medium (Thermo Fisher Scientific, Rockford, IL). Media was supplemented with 
penicillin/streptomycin (Invitrogen, CA) and 10% of fetal bovine serum (Hyclone, UT). 
Cells were sub-cultured using trypsin-EDTA (Invitrogen, CA) upon reaching 80-90% 
confluence. 
4.3.3 Experimental Design 
In order to investigate the effect of serum on SWCNT-induced IL-8 expression 
and cell proliferation, A549 cells were cultured in 24-well plates at a density of 4×10
4
 
cells/well. Cells were incubated until they reached more than 90% confluence and were 
then exposed SWCNTs. SWCNTs stock suspensions were made in both the serum free 
and serum containing media. Cells were exposed to two different concentrations (4 μg/ml 
and 8 μg/ml) of SWCNTs for 0, 1, 3, 6 and 24 hours (Figure 4.1). Cell and media 
samples were collected and immediately stored at -80
o
C until analysis. 
In order to study the effects of exposure time on SWCNT-induced IL-8 
expression and cell proliferation, A549 cells were prepared and incubated in the same 
manner described above, but were exposed to six different concentrations (2, 4, 8, 20, 40, 
and 80 μg/ml) of SWCNTs in the serum containing media for 0, 1, 3, 6 and 24 hours 
(Figure 4.2). Cell and media samples were collected and immediately stored at -80
o
C 
until analysis. 
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To study the effects of exposure and recovery time on SWCNT-induced IL-8 
expression and cell proliferation, A549 cells were prepared and incubated in the same 
manner described above. Cells were exposed to two different concentrations (4 and 
40μg/ml of SWCNTs in serum containing media for 6 (Figure 4.3) and 24 hours (Figure 
4.4). Following exposure to SWCNTs, the culture media containing SWCNTs was 
replaced with the fresh SWCNT-free media. Cells grew in the fresh media up to 96 hours. 
Cell and media samples were collected and immediately stored at -80
o
C until analysis. 
For experiments implementing a dynamic cell growth environment during 
SWCNT exposure, A549 cells were seeded at 3×10
5
 cells (per well) into six well BioFlex 
plates (Flexcell International, PA) containing 2 ml of complete F-12k medium. After cells 
reached confluence, they were exposed to SWCNTs at different concentrations (5, 10, 
and 20 μg/ml) under static or dynamic conditions for 24 hours. The dynamic cell growth 
condition was implemented using Flexcell® Tension Plus™ 4000T system, which used 
vacuum pressure to apply cyclic strain to cells cultured on BioFlex plates. During the 
course of dynamic cell growth, cyclic stretching was applied to silastic well-bottoms of 
BioFlex plates to attain 5% surface elongation at the frequency of 0.2 Hz, which 
corresponds to 45% of the total lung capacity, similar to the normal breathing conditions 
in the lung (Tschumperlin and Margulies, 1998). Directly after 24 hour exposure, both 
media and cell lysate samples were collected and stored at -80°C until analysis. 
4.3.4 Preparation of SWCNTs 
The residual metal content of the SWCNTs used in this study was 3% - 12% by 
weight, and the individual size ranges of SWCNTs were 0.8-1.2nm in diameter and 100-
1000nm in length. The SWCNTs were added to distilled water and sonicated for 10 
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minutes with 10 second cooling time per 1 minute sonication cycle using Sonicator 3000 
manufactured by Misonix (Farmingdale, NY). After sonication, a nontoxic surfactant 
polyvinylpyrrolidone (PVP) (Fisher Scientific, PA) was added to the SWCNT solution to 
inhibit the aggregation of SWCNTs in the solution. Stock suspensions of SWCNTs were 
added to cell culture media (F-12K) with or without 10% of fetal bovine serum.   
4.3.5 Cell Proliferation Assay 
Cells grown in each well were lysed using 100 µL of triton X-100 following each 
exposure condition and stored at -80°C until analysis. Total protein concentrations from 
each sample were measured using a BCA total protein assay (Pierce, IL) to evaluate cell 
proliferation.  
4.3.6 Interleukin 8 Expression 
Levels of IL-8 were determined from the supernatant of A549 cells by specific 
sandwich ELISAs, according to the manufacturer’s instructions. IL-8 human antibody 
pair and buffer kit were purchased from Invitrogen (Carlsbad, CA). 
4.3.7 Statistical Analysis 
Statistically significant differences were set p ≤ 0.05. Statistical analyses were 
carried out using one-way analyses of variance (ANOVA) followed by Dunnett’s 
multiple comparison tests. 
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4.4 Results 
4.4.1 Effects of SWCNTs on Cell Proliferation  
        and IL-8 Expression in Serum-containing and Serum-free media 
As the exposure time increased, IL-8 expression dramatically increased following 
cellular exposure to SWCNTs in serum-containing media. The level of IL-8 expression  
in serum-containing media was  significantly higher than the control (1 hour exposure) 
after 24 hours of exposure at both concentrations (4 μg/ml and 8 μg/ml) (Figure 4.1A). 
Cell proliferation was not significantly diffrent as exposure time increased at both 
concentrations (4 μg/ml and 8 μg/ml). However, cell proliferation was higher in serum-
containing media than in serum-free media at 4 μg/ml of SWCNTs (Figure 4.1B). 
4.4.2 Effects of Exposure Time on Cell Proliferation  
        and IL-8 Expression at Different Concentrations of SWCNTs 
Cells were exposed to six different concentrations ((2, 4, 8, 20, 40, 80 μg/ml)) of 
SWCNTs. IL-8 expression significantly increased (Figure 4.2A) as the exposure time 
increased over 24 hours at all concentrations of SWCNTs. However, no significant 
changes in cell proliferation were observed at most concentrations of SWCNTs during 24 
hour exposure. 
4.4.3 Effects of Recovery Time on SWCNT-induced 
         IL-8 Expression and Cell Proliferation 
Following exposure to SWCNTs at a lower concentration (4 µg/ml) for 6 hours, 
the media was replaced with fresh SWCNT-free media. 72 and 96 hours after removing 
the SWCNTs, L-8 levels were significantly higher than the levels seen in the control 
grown for the same period of time (Figure 4.3A). Protein concentrations were 
significantly higher than the 0 hour control, 48 and 96 hour after removing SWCNTs 
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(Figure 4.3B). However, following exposure to SWCNTs at a higher concentration (40 
µg/ml) for 6 hours, IL-8 expression stopped increasing after removal of SWCNTs (Figure 
4.3A). No significant change in cell proliferation was observed in this case (Figure 4.3B). 
At a longer exposure time (24 hours), the levels of IL-8 and cell proliferation were 
different. Following exposure to SWCNTs at both concentrations (4 and 40 µg/ml) for 24 
hours, IL-8 expression significantly increased after removal of SWCNTs (Figure 4.4A), 
but cell proliferation significantly decreased at both concentrations (4 and 40 µg/ml) even 
after removal of SWCNTs (Figure 4.4B). 
4.4.4 Effects of Dynamic Environment on SWCNT-induced 
         IL-8 Expression and Cell Proliferation 
To demonstrate the effects of dynamic cell growth conditions on the SWCNT-
induced IL-8 expression and cell proliferation, cells were grown in a  dynamic cell 
growth condition while being exposed to SWCNT at 5, 10, and 20 μg/ml for 24 hours 
(Figure 4.5). Following exposure to SWCNTs for 24 hours, A549 cells grown in the 
dynamic cell growth condition showed a significant increase in IL-8 level at all exposure 
concentrations as compared to cells grown in the static condition. Under the dynamic cell 
growth condition, the IL-8 levels at all SWCNT concentrations (5, 10, and 20 μg/ml) 
were significantly higher than the control (0 μg/ml after 24 hour cyclic stretching). Under 
static cell growth condition, IL-8 level was significantly higher at 20 μg/ml of SWCNTs 
than the control (0 μg/ml under static condition) (Figure 4.5A). Dynamic cell growth 
conditions also altered cell proliferation during the exposure of cells to SWCNTs. After  
24 hours of cyclic stretching in the dynamic growth environment, cells demonstrated 
increased proliferation regardless of whether SWCNT was present in their media, 
however, cells grown under static conditions did not demonstrate the same increase. 
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Following cyclic stretching for 24 hours, A549 cell proliferation was enhanced either in 
the absence (0 µg/ml) or presence (20 µg/ml) of SWCNTs (Figure 4.5B). However, cell 
proliferation was not significantly changed following exposure to SWCNTs under static 
cell growth condition. There was no significant difference in cell proliferation between 
static and dynamic cell growth conditions at SWCNTs concentrations of 5 and 10 μg/ml 
of. Cell proliferation at SWCNT concentration of 10 μg/ml of was significantly lower 
than the control (0 μg/ml after 24 hour cyclic stretching) under dynamic cell growth 
conditions (Figure 4.5B). 
4.5 Discussion 
In this study, we evaluated the pro-inflammatory effect of SWCNTs on A549 
cells under several different exposure conditions. SWCNT-induced IL-8 expression was 
enhanced in the presence of serum. IL-8 expression was induced by SWCNTs and kept 
increasing even after removing SWCNTs; especially following exposure to lower 
concentrations of SWCNTs. SWCNT exposure under dynamic cell growth conditions 
induced changes in IL-8 expression and cell proliferation. However, we did not observe 
any significant change in IL-8 expression with increasing concentration, although we 
observed significant change in the levels of another inflammatory marker (i.e. nitric oxide 
(NO) in both A549 and primary normal human bronchial epithelial (NHBE) cells in a 
previous publication 
33
. Interestingly, Herzog and co-workers showed that SWCNT 
suppressed inflammatory responses (IL-8 and IL-6 expression) in A549 cells 
31
. In the 
case of nanomaterials, the uncertainties are great because the characteristics of 
nanoparticles may be different from those of larger particles with the same chemical 
composition.   
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Figure 4.1 Effects of SWCNTs on cell proliferation and IL-8 expression in serum-
containing and serum-free media. IL-8 was measured by ELISA (Figure  
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Figure 4.1 (continued) 
                     4.1A) and total protein concentration was determined by the BCA protein 
assay (Figure 4.1B), following exposure of SWCNTs at 4 µg/ml  
µg/ml either in the presence (10% of serum in the media) or absence of 
serum. * denotes a significant difference between data in the serum 
containing and serum free media (p<0.05). # denotes a significantly higher 
difference than the 1 hour exposure control (p<0.05). 
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Figure 4.2 Effects of exposure time on cell proliferation and IL-8 expression at    
different concentrations of SWCNTs. A549 cells were exposed to SWCNTs  
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Figure 4.2 (continued) 
at six different concentrations, IL-8 and cell proliferation were measured as 
exposure time increased. IL-8 was measured by ELISA (Figure 4.2A) and 
total protein concentration was determined by the BCA protein assay 
(Figure 4.2B). 0 hour were used as control. * denotes a significantly higher 
(or lower) difference than the control (0 hour) (p< 0.05). 
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Figure 4.3  Effects of recovery time on SWCNT-induced IL-8 expression. A549 cells  
were exposed to SWCNTs at low and high concentrations for 6 hours,  
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Figure 4.3 (continued) 
                   media was then replaced with SWCNT-free media. IL-8 and cell proliferation 
were consistently measured at 0, 24, 48, 96 hour after removal of SWCNTs. 
IL-8 was measured by ELISA (Figure 4.3A) and total protein concentration 
was determined by the BCA protein assay (Figure 4.3B). Untreated samples 
and 0 hour were used as controls.  * denotes a significantly higher difference 
than the control (0 hour) (p< 0.05). # denotes a significantly higher difference 
than the same time point control at 0 µg/ml of SWCNTs (p< 0.05). 
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Figure 4.4 Effects of recovery time on SWCNT-induced IL-8 expression. A549 cells 
were exposed to SWCNTs at low and high concentrations for 24 hours, 
media was then replaced with SWCNT-free media.  
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Figure 4.4 (continued) 
                   IL-8 and cell proliferation were consistently measured at 0, 24, 48, 96 hour 
after removal of SWCNTs. IL-8 was measured by ELISA (Figure 4.4A) and 
total protein concentration was determined by the BCA protein assay (Figure 
4.4B). Untreated (0 µg/ml of SWCNTs) and 0 hour samples were used as 
controls. *denotes a significantly higher difference than the control (0 hour) 
(p< 0.05). # denotes a significantly higher difference than the same time 
point control at 0 µg/ml of SWCNTs (p< 0.05). 
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Figure 4.5 Effects of the dynamic environment on SWCNT-induced IL-8 expression and 
A549 cell proliferation. A549 cells were exposed to SWCNTs at 5, 10, and 
20 µg/ml. Cells were grown under static and dynamic cell growth conditions  
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Figure 4.5 (continued) 
                   for 24 hours. IL-8 was measured from culture media to characterize the 
inflammatory response of A549 cells exposed to different concentrations of 
SWCNTs under static and dynamic cell growth conditions (Figure 4.5A). 
Total amount of protein was measured from cell lysate of each sample 
(Figure 4.5B). * denotes a significantly higher difference than the static 
condition at each concentration of SWCNT (p<0.03 in Figure 5A and p<0.05 
in Figure 5B). # denote a significantly higher (or lower) difference than the 
control for dynamic cell growth condition (p<0.05). 
In this study, the changes in cell proliferation were not time-dependent or 
insignificant following exposure to SWCNTs. The SWCNT exposure started following 
confluence of cells. Some fluctuation in cell proliferation can be explained by likely 
damage to cellular components, while cells continued to proliferate. This was especially 
evident in the dynamic cell growth condition where part of the cell layers may have 
repeatedly detached and been recovered. 
Previous studies showed that SWCNTs strongly interact with a large range of 
molecular species.
38-43
 Higher toxicity was previously observed in samples that were 
exposure to SWCNTs at high concentrations (400- 800μg/ml) when grown in serum-free 
media.
44
 However, at the lower concentrations (4 and 8 µg/ml) of SWCNTs from this 
study, higher inflammatory responses were observed in the presence of serum (Figure 
4.1A) while no significant decrease in cell proliferations was observed (Figure 4.1B). 
Increased toxicity might be due to nutrient deficiencies and higher concentration of 
SWCNTs.
44-46
 In this study, we observed that more SWNCTs penetrated into the cell in 
79 
 
 
 
the presence of serum (data not shown). Casey and co-workers suggested that SWCNTs 
may interact with media components by physical adsorption such as van der Waals force. 
They also demonstrated that serum affected the dispersion of the nanotubes.
35
 Facilitated 
translocation of SWCNTs into the cells in the presence of serum might affect the 
enhanced IL-8 expression. However, the mechanism of the interaction between SWCNTs 
and unknown components of serum is not yet clear.  
SWCNTs at high concentration (40 µg/ml) were more agglomerated. When we 
replaced the SWCNTs-containing media with fresh culture media following a 6 hour 
exposure, the aggregated forms of SWCNTs were more efficiently removed. In this case, 
IL-8 expression did not increase after removing SWCNTs following a shorter exposure (6 
hour exposure) (Figure 3A). However, IL-8 expression kept increasing even after 
removal of SWCNTs following a relatively longer exposure (24 hours) (Figure 4.4A). 
Cell proliferation was also reduced after longer exposure times to higher concentrations 
of SWCNTs. Although their experimental systems were different from ours, other studies 
demonstrated that higher apoptotic cell death was observed at lower SWCNT exposure 
concentrations than higher concentrations in mouse model 
27,47
. The effects of SWCNTs 
on cell proliferation and inflammatory responses were different between experimental 
systems (i.e. in vitro and animal model, static and dynamic systems) 
48
. In our study, the 
SWCNT-induced IL-8 expression was significantly higher in the dynamic condition than 
in the static condition. An increased level of IL-8 under dynamic cell growth conditions 
could be due to the initial increase in IL-8 caused by the implementation of a dynamic 
cell growth condition 
49,50
. Elevated levels of pro-inflammatory cytokines during 
SWCNT exposure under a dynamic cell growth condition may result from the altered 
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interaction between SWCNTs and A549 cell monolayers. Moreover, due to this altered 
interaction, cell proliferation was dramatically changed under dynamic cell growth 
conditions. Our results showed that the levels of inflammatory response could be altered 
under different exposure conditions. To identify the mechanisms of nanoparticle-induced 
inflammatory response under different exposure conditions, other inflammatory markers 
and various candidate biological markers (cellular component, macromolecules, other 
metabolic parameters, and cellular function) need to be monitored. In addition, 
comparative studies with normal cell lines and novel experimental set-ups for 
multiplexed screening of biological markers will be required to unravel the uncertainty of 
nanoparticle-induced inflammatory responses 
51
. Continued in vivo and in vitro 
toxicological research is needed to identify potential health endpoints related to 
occupational exposure to engineered nanoparticles. Epidemiological studies of exposed 
workers will be needed to establish associations between exposures to engineered 
nanoparticles and adverse health effects and to assess other potential exposure-response 
relationships.  
References 
1. Foldvari, M. & Bagonluri, M. Carbon nanotubes as functional excipients for 
nanomedicines: II. Drug delivery and biocompatibility issues. Nanomedicine 4, 
183-200 (2008). 
 
2. Harrison, B.S. & Atala, A. Carbon nanotube applications for tissue engineering. 
Biomaterials 28, 344-353 (2007). 
 
3. Lam, C.W., James, J.T., McCluskey, R., Arepalli, S. & Hunter, R.L. A review of 
carbon nanotube toxicity and assessment of potential occupational and 
environmental health risks. Crit. Rev. Toxicol. 36, 189-217 (2006). 
 
4. Iijima, S. Helical microtubules of graphitic carbon. Nature 354, 56-58 (1991). 
81 
 
 
 
5. Miyagawa, H., Misra, M. & Mohanty, A.K. Mechanical properties of carbon 
nanotubes and their polymer nanocomposites. J. Nanosci. Nanotechnol. 5, 1593-
1615 (2005). 
 
6. Cherukuri, P., Bachilo, S.M., Litovsky, S.H. & Weisman, R.B. Near-infrared 
fluorescence microscopy of single-walled carbon nanotubes in phagocytic cells. J. 
Am. Chem. Soc. 126, 15638-15639 (2004). 
 
7. Ferrari, M. Cancer nanotechnology: Opportunities and challenges. Nat. Rev. 
Cancer 5, 161-171 (2005). 
 
8. Ferrari, M. Nanovector therapeutics. Curr. Opin. Chem. Biol. 9, 343-346 (2005). 
9. Martin, C.R. & Kohli, P. The emerging field of nanotube biotechnology. Nat. Rev. 
Drug Discov. 2, 29-37 (2003). 
 
10. de Jonge, N. & Bonard, J.M. Carbon nanotube electron sources and applications. 
Philos. Trans. R. Soc. Lond. Ser. A-Math. Phys. Eng. Sci. 362, 2239-2266 (2004). 
 
11. Endo, M., Hayashi, T., Kim, Y.A., Terrones, M. & Dresselhaus, M.S. 
Applications of carbon nanotubes in the twenty-first century. Philos. Trans. R. 
Soc. Lond. Ser. A-Math. Phys. Eng. Sci. 362, 2223-2238 (2004). 
 
12. Muller, J., Huaux, F. & Lison, D. Respiratory toxicity of carbon nanotubes: how 
worried should we be? Carbon 44, 1048-1056 (2006). 
 
13. Colvin, V.L. The potential environmental impact of engineered nanomaterials. 
Nat. Biotechnol. 21, 1166-1170 (2003). 
 
14. Hurt, R.H., Monthioux, M. & Kane, A. Toxicology of carbon nanomaterials: 
Status, trends, and perspectives on the special issue. Carbon 44, 1028-1033 
(2006). 
 
15. Manna, S.K., et al. Single-walled carbon nanotube induces oxidative stress and 
activates nuclear transcription factor-kappaB in human keratinocytes. Nano Lett. 
5, 1676-1684 (2005). 
 
16. Oberdorster, G., et al. Principles for characterizing the potential human health 
effects from exposure to nanomaterials: elements of a screening strategy. Part 
Fibre Toxicol. 2, 8 (2005). 
 
17. Service, R.F. Nanotoxicology: nanotechnology grows up. Science 304, 1732-1734 
(2004). 
 
18. Service, R.F. Nanotechnology. Calls rise for more research on toxicology of 
nanomaterials. Science 310, 1609 (2005). 
82 
 
 
 
19. Smart, S.K., Cassady, A.I., Lu, G.Q. & Martin, D.J. The biocompatibility of 
carbon nanotubes. Carbon 44, 1034-1047 (2006). 
 
20. Shvedova, A.A., et al. Unusual inflammatory and fibrogenic pulmonary responses 
to single-walled carbon nanotubes in mice. Am. J. Physiol. Lung Cell. Mol 
Physiol. 289, L698-708 (2005). 
 
21. Warheit, D.B., et al. Comparative pulmonary toxicity assessment of single-wall 
carbon nanotubes in rats. Toxicol. Sci. 77, 117-125 (2004). 
 
22. Donaldson, K., et al. Concordance between in vitro and in vivo dosimetry in the 
proinflammatory effects of low-toxicity, low-solubility particles: the key role of 
the proximal alveolar region. Inhal. Toxicol. 20, 53-62 (2008). 
 
23. Li, Z., et al. Cardiovascular effects of pulmonary exposure to single-wall carbon 
nanotubes. Environ. Health Perspect. 115, 377-382 (2007). 
 
24. Radomski, A., et al. Nanoparticle-induced platelet aggregation and vascular 
thrombosis. Br. J. Pharmacol. 146, 882-893 (2005). 
 
25. Oberdorster, G., et al. Extrapulmonary translocation of ultrafine carbon particles 
following whole-body inhalation exposure of rats. J. Toxicol. Environ. Health A 
65, 1531-1543 (2002). 
 
26. Elder, A., et al. Translocation of inhaled ultrafine manganese oxide particles to 
the central nervous system. Environ Health Perspect 114, 1172-1178 (2006). 
 
27. Chou, C.C., et al. Single-walled carbon nanotubes can induce pulmonary injury in 
mouse model. Nano Lett. 8, 437-445 (2008). 
 
28. Allermann, L. & Poulsen, O.M. Interleukin-8 secretion from monocytic cell lines 
for evaluation of the inflammatory potential of organic dust. Environ. Res. 88, 
188-198 (2002). 
 
29. Choi, S.J., Oh, J.M. & Choy, J.H. Toxicological effects of inorganic nanoparticles 
on human lung cancer A549 cells. J. Inorg. Biochem. 103, 463-471 (2009). 
 
30. Duffin, R., Tran, L., Brown, D., Stone, V. & Donaldson, K. Proinflammogenic 
effects of low-toxicity and metal nanoparticles in vivo and in vitro: Highlighting 
the role of particle surface area and surface reactivity. Inhal. Toxicol. 19, 849-856 
(2007). 
 
31. Herzog, E., et al. SWCNT suppress inflammatory mediator responses in human 
lung epithelium in vitro. Toxicol. Appl. Pharmacol. 234, 378-390 (2009). 
 
83 
 
 
 
32. Mitchell, L.A., et al. Pulmonary and systemic immune response to inhaled 
multiwalled carbon nanotubes. Toxicol. Sci. 100, 203-214 (2007). 
 
33. Stoker, E., Purser, F., Kwon, S., Park, Y.B. & Lee, J.S. Alternative estimation of 
human exposure of single-walled carbon nanotubes using three-dimensional 
tissue-engineered human lung. Int. J. Toxicol. 27, 441-448 (2008). 
 
34. Zhang, L.W., Zeng, L., Barron, A.R. & Monteiro-Riviere, N.A. Biological 
interactions of functionalized single-wall carbon nanotubes in human epidermal 
keratinocytes. Int. J. Toxicol. 26, 103-113 (2007). 
 
35. Casey, A., et al. Probing the interaction of single walled carbon nanotubes within 
cell culture medium as a precursor to toxicity testing. Carbon 45, 34-40 (2007). 
 
36. Lam, C.W., James, J.T., McCluskey, R., Arepalli, S. & Hunter, R.L. A review of 
carbon nanotube toxicity and assessment of potential occupational and 
environmental health risks. Crit. Rev. Toxicol. 36, 189-217 (2006). 
 
37. Ye, S.F., Wu, Y.H., Hou, Z.Q. & Zhang, Q.Q. ROS and NF-kappaB are involved 
in upregulation of IL-8 in A549 cells exposed to multi-walled carbon nanotubes. 
Biochem. Biophys. Res. Commun. 379, 643-648 (2009). 
 
38. Bandyopadhyaya, R., Nativ-Roth, E., Regev, O. & Yerushalmi-Rozen, R. 
Stabilization of individual carbon nanotubes in aqueous solutions. Nano Lett. 2, 
25-28 (2002). 
 
39. Casey, A., Farrell, G.F., McNamara, M., Byrne, H.J. & Chambers, G. Interaction 
of carbon nanotubes with sugar complexes. Synth. Met. 153, 357-360 (2005). 
 
40. Casey, A., et al. Single walled carbon nanotubes induce indirect cytotoxicity by 
medium depletion in A549 lung cells. Toxicol Lett. 179, 78-84 (2008). 
 
41. Keogh, S.M., et al. Temperature-induced nucleation of poly(p-phenylene 
vinylene-co-2,5-dioctyloxy-m-phenylene vinylene) crystallization by HiPco 
single-walled carbon nanotubes. J. Phys. Chem. B 109, 5600-5607 (2005). 
 
42. Moulton, S.E., et al. Biomolecules as selective dispersants for carbon nanotubes. 
Carbon 43, 1879-1884 (2005). 
 
43. Salvador-Morales, C., et al. Complement activation and protein adsorption by 
carbon nanotubes. Mol. Immunol. 43, 193-201 (2006). 
 
44. Davoren, M., et al. In vitro toxicity evaluation of single walled carbon nanotubes 
on human A549 lung cells. Toxicol. In Vitro 21, 438-448 (2007). 
84 
 
 
 
45. Antonini, J.M. & Reasor, M.J. Effect of short-term exogenous pulmonary 
surfactant treatment on acute lung damage associated with the intratracheal 
instillation of silica. J. Toxicol. Environ. Health 43, 85-101 (1994). 
 
46. Ozturk, S., Kaseko, G., Mahaworasilpa, T. & Coster, H.G. Adaptation of cell 
lines to serum-free culture medium. Hybrid Hybridomics 22, 267-272 (2003). 
 
47. Jacobsen, N.R., et al. Lung inflammation and genotoxicity following pulmonary 
exposure to nanoparticles in ApoE-/- mice. Part Fibre Toxicol.6, 2 (2009). 
 
48. Jones, C.F. & Grainger, D.W. In vitro assessments of nanomaterial toxicity. Adv. 
Drug Delivery Reviews 61, 438-456 (2009). 
 
49. Patel, H. & Kwon, S. Interplay Between Cytokine-Induced and Cyclic Equibiaxial 
Deformation-Induced Nitric Oxide Production and Metalloproteases Expression 
in Human Alveolar Epithelial Cells. Cell. and Molec. Bioengineering 2, 615-624 
(2009). 
 
50. Yamamoto, H., Teramoto, H., Uetani, K., Igawa, K. & Shimizu, E. Stretch 
induces a growth factor in alveolar cells via protein kinase. Respir. Physiol. 127, 
105-111 (2001). 
 
51. Schulte, P.A. The use of biomarkers in surveillance, medical screening, and 
intervention. Mutat. Res. 592, 155-163 (2005). 
 
 
  
85 
 
 
 
CHAPTER 5 
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS 
5.1 Summary and Conclusions 
Carbon nanotubes have been widely used in biomedical engineering and materials 
science, especially since researchers suggest CNTs might be able to be used  to bone 
tissue engineering application. At the same time, the urgent need for toxicological studies 
on carbon nanotubes has arisen. The objectives of this research were to estimate the 
CNTs-collagen scaffolds in tissue engineering application, and to find out the effect of 
exposure conditions on SWCNT-induced inflammatory response in human alveolar 
epithelial cells.  
5.1.1 Applications of CNTs-collagen scaffolds in tissue engineering 
In Chapter 3, we designed CNTs –collagen composite scaffolds using different 
types of MWCNT (functionalized and non-functionalized) with good optically 
transparent.  Then the mesenchymal stem cell’s viability, differentiation, mineralization 
and inflammatory response on those scaffolds were studied. The aim of this study was to 
test whether those type of scaffolds can improve mesenchymal stem cell differentiation 
and mineralization without changing too much of the cell viability and inflammatory 
marker release. The cell differentiation and mineralization levels were higher in the 
MWCNTs and collagen mixture scaffolds than the plastic-only and collagen-only were.  
The cell viability and inflammatory maker IL-6 level didn’t change too much when 
comparing different types of MWCNT-collagen mixture scaffolds. Those results  
suggested that MWCNT and collagen mixture scaffolds might be able to provide a good 
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nanostructure, mechanical binding and stiffness for MSC differentiation and 
mineralization.  
5.1.2 Toxicity assessment of SWCNT  
In Chapter 4, inflammatory marker (IL-8) expression in human alveolar epithelial 
cells under several different exposure conditions of SWCNT was measured. In this study 
we found IL-8 expression was enhanced in the presence of serum, and at low 
concentrations IL-8 expression kept increasing even after removal of  SWCNTs from the 
media.  We therefore surmise that serum was a defensive response of these lung cells to 
SWCNT exposure. Also the less aggregation of low concentrations of SWCNT might be 
the reason why IL-8 expression kept increasing even after removing SWCNTs,  
SWCNTs without aggregation were easily getting  into cell and breaking down some 
mechanism of cell.  
5.2 Recommendations 
There has been a growth of interest in carbon nanotube materials because of their 
huge potential in industrial and research applications.  Several studies of the application 
of carbon nanotubes have been carried for the substrate of cell culture, drug delivery 
systems and medical implant materials. However, there are not many researchers using 
CNT and collagen to test MSC`s viability and proliferation, especially no studies using 
CNT and collagen composite for estimating MSC`s differentation and mineralization. 
Our study does show the MWCNT-collagen composite increased in the cell 
differentiation and mineralization level, than the plastic and collagen-only surface. But 
the mechanism of the interaction between MWCNT, collagen and cell were not clear yet. 
Therefore, efforts should be made to force on mechanical study of MWCNT and collagen. 
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When considering the possible reason why cell differentiation and mineralization were 
changed, it seems important for future studies to address the possible study of the 
interaction between the MWCNT and collagen fiber, the surface properties of those 
composite scaffolds, and the interaction between the scaffold and cell.  In addition, 
several studies on the effect of SWCNT on the lung tissue have been reported and there 
appears to be some inconsistency between the research findings. The conclusions we got 
during our research do show SWCNTs toxicity change at different exposure conditions, 
however, the reason behind that is not conclusive yet. Efforts should also be devoted to 
identifying the determinate of SWCNTs toxicity. In this respect, it can be recommended 
that more in vivo and in vitro toxicological research is needed to identify potential health 
endpoints related to occupational exposure to engineered nanoparticles. 
 
